Global I.V. Cannula Market By Clinical Indication (Dehydration, Nutrition, Shock, Surgery, Blood Transfusions, Chemotherapy, Medication Administration, Others); By Type (Wing/ Butterfly, Pen/ Straight, Y-type, Scalp-Type, Injection-Port Type, Others); By Needle Type (14 to 20 G, 20 to 29 G, Others); By End User (Hospital, Clinics, Ambulatory Surgical Centers, Others); By Region (North America (U.S., Canada, Mexico, Rest Of North America), Europe (France, The UK, Spain, Germany, Italy, Denmark, Finland, Iceland, Sweden, Norway, Belgium, The Netherlands, Luxembourg, Rest of Europe), Asia Pacific (China, Japan, India, New Zealand, Australia, South Korea, Southeast Asia, Indonesia, Thailand, Malaysia, Singapore, Rest of Southeast Asia, Rest of Asia Pacific, Middle East & Africa (Saudi Arabia, UAE, Egypt, Kuwait, South Africa, Rest of Middle East & Africa) Latin America (Brazil, Argentina, Rest of Latin America)) - Global Insights, Growth, Size, Comparative Analysis, Trends and Forecast, 2022 – 2030
Industry Trends
In terms of revenue, the global I.V. cannula market was valued at US$ 312 Mn in 2021, growing at an estimated CAGR of 7.5% over the forecast period. One of the best ways to treat anyone is directly administering the drug or medical through veins. It is not just time saving but also extremely effective most likely ensuring expected results. Intravenous cannula primarily happens to a small tube made up from plastic and is usually inserted in the vein located in one’s arm. It is basically used to supply fluids if one cannot drink or is suffering from dehydration. I.V. cannula is also used to grant transfusion of blood and administering drugs or medications straight into one’s blood stream. Extensive use of I.V. cannula is the reason why this market has been continuously growing.
While the coronavirus pandemic proved fatal for the mankind and most of the industries, the health sector despite suffering hardships saw massive growth. The demand for I.V. cannula’s skyrocketed as numerous patients were being admitted and treated for the highly infectious virus. The I.V. cannula market was successful in generating huge amount of revenue in the times of the pandemic.
Clinical Indication Outlook
On the basis of clinical indication, the I.V. cannula market has been divided into dehydration, nutrition, shock, surgery, blood transfusions, chemotherapy, medication administration and others. While the I.V. cannula is a go to solution in case of the dehydration, it is also an important way to administer drugs post surgeries. Also the rise in the number of people suffering from chronic diseases like cancer has spiked chemotherapies, which ultimately helps this market grow.
Type Outlook
On the basis of type, the I.V. cannula market has been segmented into wing/ butterfly, pen/ straight, Y-type, scalp-type, injection-port of type and others. The wing/ butterfly segment accounts for maximum amount of revenue generated by this market. This type of cannula comes with butterfly needle which is used to reach a vein in order to draw blood or to administer drugs. It has plastic wings on both the sides of a needle that is hollow and this is the reason it is also called wing type I.V. cannula.
Global I.V. Cannula Market Revenue & Forecast, (US$ Million), 2022 – 2030
Needle Type Outlook
The needle type segment of the I.V. cannula market has been categorised into 14 to 20 G, 20 to 29 G, and others. G here stands for ‘Gauge’ and a 14 to 20 G needle is majorly used to infuse blood or fluids quickly at the time of surgery or a trauma. The 20 to 29 G needle is used for subcutaneous, intramuscular and other injections.
End User Outlook
The end user segment of the I.V. cannula market has been bifurcated into hospital, clinics, ambulatory surgical centers, and others. The hospital segment accounts for most amount of revenue minted by this market. The number of people seek treatment in hospitals in the highest and the demand from these places for I.V. cannulas is the maximum.
Region Outlook
On the basis of region, the I.V. cannula market has been divided into Latin America, Europe, North America, Asia-Pacific and others. The region of the North America accounts for majority of revenue generated by this market. Major reason why this region dominates is the massive progress witnessed by healthcare sector in nations like the United States and Canada. The technological advancements in medical sector and availability of better hospitals also contributes to the growth of the I.V. cannula market.
Competitive Landscape
The report provides both, qualitative and quantitative research of I.V. cannula market as well as provides comprehensive insights and development methods adopted by the key contenders. The report also offers extensive research on the key players in this market and details on the competitiveness of these players. Key business strategies such as mergers and acquisitions (M&A), affiliations, collaborations, and contacts adopted by these major market participants are also recognized and analysed in the report. For each company, the report studies their global presence, competitors, service offerings and specification amongst others.
Some of the major players operating in the I.V. cannula market are listed below:
- AdvaCare Pharma
- Angiplast PVT LTD
- Henry Schein Medical
- iLife Medical Devices Private Limited
- Lars medicare Pvt Ltd
- Mediplus (India) Ltd.
- Neotec Medical
- Sterimed Group
- Well Med India
- Other Market Participants
Global I.V. Cannula Market
By Clinical Indication
- Dehydration
- Nutrition
- Shock
- Surgery
- Blood Transfusions
- Chemotherapy
- Medical Administration
- Others
By Type
- Wing/ Butterfly
- Pen/ Straight
- Y-Type
- Scalp-Type
- Injection-Port Type
- Others
By Needle Type
- 14 to 20 G
- 20 to 29 G
- Others
By End User
- Hospital
- Clinics
- Ambulatory Surgical Centers
- Others
By Region
- North America
- U.S
- Canada
- Mexico
- Rest of North America
- Europe
- France
- The UK
- Spain
- Germany
- Italy
- Nordic Countries
- Denmark
- Finland
- Iceland
- Sweden
- Norway
- Benelux Union
- Belgium
- The Netherlands
- Luxembourg
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- New Zealand
- Australia
- South Korea
- Southeast Asia
- Indonesia
- Thailand
- Malaysia
- Singapore
- Rest of Southeast Asia
- Rest of Asia Pacific
- Middle East and Africa
- Saudi Arabia
- UAE
- Egypt
- Kuwait
- South Africa
- Rest of Middle East & Africa
- Latin America
- Brazil
- Argentina
- Rest of Latin America
Table of Contents
1.
Market Scope
1.1. Market Segmentation
1.2. Years Considered
1.2.1.
Historic Years: 2015 - 2020
1.2.2.
Base Year: 2021
1.2.3.
Forecast Years: 2022 - 2030
2.
Key Target Audiences
3. Research Methodology
3.1. Primary Research
3.1.1.
Research Questionnaire
3.1.2.
Global Percentage Breakdown
3.1.3.
Primary Interviews: Key Opinion Leaders
(KOLs)
3.2.
Secondary Research
3.2.1.
Paid Databases
3.2.2.
Secondary Sources
3.3.
Market Size Estimates
3.3.1.
Top-Down Approach
3.3.2.
Bottom-Up Approach
3.4.
Data Triangulation Methodology
3.5.
Research Assumptions
4.
Recommendations
and Insights from AMI’s Perspective**
5. Holistic Overview
of I.V. Cannula Market
6.
Market Synopsis: I.V. Cannula Market
7. I.V. Cannula Market
Analysis: Qualitative Perspective
7.1. Introduction
7.1.1.
Product Definition
7.1.2.
Industry Development
7.2.
Market Dynamics
7.2.1.
Drivers
7.2.2.
Restraints
7.2.3.
Opportunities
7.3. Trends in I.V. Cannula Market
7.4.
Market Determinants Radar Chart
7.5.
Macro-Economic and Micro-Economic Indicators: I.V.
Cannula Market
7.6.
Porter’s Five Force Analysis
7.7. Impact of Covid-19 on I.V. Cannula
Market
8.
Global I.V. Cannula
Market Analysis and Forecasts, 2022 - 2030
8.1. Overview
8.1.1.
Global I.V. Cannula
Market Revenue (US$ Mn)
8.2.
Global I.V. Cannula
Market Revenue (US$ Mn) and Forecasts, By Clinical Indication
8.2.1.
Dehydration
8.2.1.1.
Definition
8.2.1.2.
Market Estimation and Penetration, 2015 - 2021
8.2.1.3.
Market Forecast, 2022 - 2030
8.2.1.4.
Compound Annual Growth Rate (CAGR)
8.2.1.5.
Regional Bifurcation
8.2.1.5.1.
North America
8.2.1.5.1.1.
Market Estimation, 2015 - 2021
8.2.1.5.1.2.
Market Forecast, 2022 - 2030
8.2.1.5.2.
Europe
8.2.1.5.2.1.
Market Estimation, 2015 - 2021
8.2.1.5.2.2.
Market Forecast, 2022 - 2030
8.2.1.5.3.
Asia Pacific
8.2.1.5.3.1.
Market Estimation, 2015 - 2021
8.2.1.5.3.2.
Market Forecast, 2022 - 2030
8.2.1.5.4.
Middle East and Africa
8.2.1.5.4.1.
Market Estimation, 2015 - 2021
8.2.1.5.4.2.
Market Forecast, 2022 - 2030
8.2.1.5.5.
Latin America
8.2.1.5.5.1.
Market Estimation, 2015 - 2021
8.2.1.5.5.2.
Market Forecast, 2022 - 2030
8.2.2.
Nutrition
8.2.2.1.
Definition
8.2.2.2.
Market Estimation and Penetration, 2015 - 2021
8.2.2.3.
Market Forecast, 2022 - 2030
8.2.2.4.
Compound Annual Growth Rate (CAGR)
8.2.2.5.
Regional Bifurcation
8.2.2.5.1.
North America
8.2.2.5.1.1.
Market Estimation, 2015 - 2021
8.2.2.5.1.2.
Market Forecast, 2022 - 2030
8.2.2.5.2.
Europe
8.2.2.5.2.1.
Market Estimation, 2015 - 2021
8.2.2.5.2.2.
Market Forecast, 2022 - 2030
8.2.2.5.3.
Asia Pacific
8.2.2.5.3.1.
Market Estimation, 2015 - 2021
8.2.3.
Shock
8.2.3.1.1.1.
Market Forecast, 2022 - 2030
8.2.3.1.2.
Middle East and Africa
8.2.3.1.2.1.
Market Estimation, 2015 - 2021
8.2.3.1.2.2.
Market Forecast, 2022 - 2030
8.2.3.1.3.
Latin America
8.2.3.1.3.1.
Market Estimation, 2015 -
2021
8.2.3.1.3.2.
Market Forecast, 2022 - 2030
8.2.3.2.
Definition
8.2.3.3.
Market Estimation and Penetration, 2015 - 2021
8.2.3.4.
Market Forecast, 2022 - 2030
8.2.3.5.
Compound Annual Growth Rate (CAGR)
8.2.3.6.
Regional Bifurcation
8.2.3.6.1.
North America
8.2.3.6.1.1.
Market Estimation, 2015 - 2021
8.2.3.6.1.2.
Market Forecast, 2022 - 2030
8.2.3.6.2.
Europe
8.2.3.6.2.1.
Market Estimation, 2015 - 2021
8.2.3.6.2.2.
Market Forecast, 2022 - 2030
8.2.3.6.3.
Asia Pacific
8.2.3.6.3.1.
Market Estimation, 2015 - 2021
8.2.3.6.3.2.
Market Forecast, 2022 - 2030
8.2.3.6.4.
Middle East and Africa
8.2.3.6.4.1.
Market Estimation, 2015 - 2021
8.2.3.6.4.2.
Market Forecast, 2022 - 2030
8.2.3.6.5.
Latin America
8.2.3.6.5.1.
Market Estimation, 2015 - 2021
8.2.3.6.5.2.
Market Forecast, 2022 - 2030
8.2.4.
Surgery
8.2.4.1.
Definition
8.2.4.2.
Market Estimation and Penetration, 2015 - 2021
8.2.4.3.
Market Forecast, 2022 - 2030
8.2.4.4.
Compound Annual Growth Rate (CAGR)
8.2.4.5.
Regional Bifurcation
8.2.4.5.1.
North America
8.2.4.5.1.1.
Market Estimation, 2015 - 2021
8.2.4.5.1.2.
Market Forecast, 2022 - 2030
8.2.4.5.2.
Europe
8.2.4.5.2.1.
Market Estimation, 2015 - 2021
8.2.4.5.2.2.
Market Forecast, 2022 - 2030
8.2.4.5.3.
Asia Pacific
8.2.4.5.3.1.
Market Estimation, 2015 - 2021
8.2.4.5.3.2.
Market Forecast, 2022 - 2030
8.2.4.5.4.
Middle East and Africa
8.2.4.5.4.1.
Market Estimation, 2015 - 2021
8.2.4.5.4.2.
Market Forecast, 2022 - 2030
8.2.4.5.5.
Latin America
8.2.4.5.5.1.
Market Estimation, 2015 - 2021
8.2.4.5.5.2.
Market Forecast, 2022 - 2030
8.2.5.
Blood Transfusions
8.2.5.1.
Definition
8.2.5.2.
Market Estimation and Penetration, 2015 - 2021
8.2.5.3.
Market Forecast, 2022 - 2030
8.2.5.4.
Compound Annual Growth Rate (CAGR)
8.2.5.5.
Regional Bifurcation
8.2.5.5.1.
North America
8.2.5.5.1.1.
Market Estimation, 2015 - 2021
8.2.5.5.1.2.
Market Forecast, 2022 - 2030
8.2.5.5.2.
Europe
8.2.5.5.2.1.
Market Estimation, 2015 - 2021
8.2.5.5.2.2.
Market Forecast, 2022 - 2030
8.2.5.5.3.
Asia Pacific
8.2.5.5.3.1.
Market Estimation, 2015 - 2021
8.2.5.5.3.2.
Market Forecast, 2022 - 2030
8.2.5.5.4.
Middle East and Africa
8.2.5.5.4.1.
Market Estimation, 2015 - 2021
8.2.5.5.4.2.
Market Forecast, 2022 - 2030
8.2.5.5.5.
Latin America
8.2.5.5.5.1.
Market Estimation, 2015 - 2021
8.2.5.5.5.2.
Market Forecast, 2022 - 2030
8.2.6.
Chemotherapy
8.2.6.1.
Definition
8.2.6.2.
Market Estimation and Penetration, 2015 - 2021
8.2.6.3.
Market Forecast, 2022 - 2030
8.2.6.4.
Compound Annual Growth Rate (CAGR)
8.2.6.5.
Regional Bifurcation
8.2.6.5.1.
North America
8.2.6.5.1.1.
Market Estimation, 2015 - 2021
8.2.6.5.1.2.
Market Forecast, 2022 - 2030
8.2.6.5.2.
Europe
8.2.6.5.2.1.
Market Estimation, 2015 - 2021
8.2.6.5.2.2.
Market Forecast, 2022 - 2030
8.2.6.5.3.
Asia Pacific
8.2.6.5.3.1.
Market Estimation, 2015 - 2021
8.2.6.5.3.2.
Market Forecast, 2022 - 2030
8.2.6.5.4.
Middle East and Africa
8.2.6.5.4.1.
Market Estimation, 2015 - 2021
8.2.6.5.4.2.
Market Forecast, 2022 - 2030
8.2.6.5.5.
Latin America
8.2.6.5.5.1.
Market Estimation, 2015 - 2021
8.2.6.5.5.2.
Market Forecast, 2022 - 2030
8.2.7.
Medication Administration
8.2.7.1.
Definition
8.2.7.2.
Market Estimation and Penetration, 2015 - 2021
8.2.7.3.
Market Forecast, 2022 - 2030
8.2.7.4.
Compound Annual Growth Rate (CAGR)
8.2.7.5.
Regional Bifurcation
8.2.7.5.1.
North America
8.2.7.5.1.1.
Market Estimation, 2015 - 2021
8.2.7.5.1.2.
Market Forecast, 2022 - 2030
8.2.7.5.2.
Europe
8.2.7.5.2.1.
Market Estimation, 2015 - 2021
8.2.7.5.2.2.
Market Forecast, 2022 - 2030
8.2.7.5.3.
Asia Pacific
8.2.7.5.3.1.
Market Estimation, 2015 - 2021
8.2.7.5.3.2.
Market Forecast, 2022 - 2030
8.2.7.5.4.
Middle East and Africa
8.2.7.5.4.1.
Market Estimation, 2015 - 2021
8.2.7.5.4.2.
Market Forecast, 2022 - 2030
8.2.7.5.5.
Latin America
8.2.7.5.5.1.
Market Estimation, 2015 - 2021
8.2.7.5.5.2.
Market Forecast, 2022 - 2030
8.2.8.
Others
8.2.8.1.
Definition
8.2.8.2.
Market Estimation and Penetration, 2015 - 2021
8.2.8.3.
Market Forecast, 2022 - 2030
8.2.8.4.
Compound Annual Growth Rate (CAGR)
8.2.8.5.
Regional Bifurcation
8.2.8.5.1.
North America
8.2.8.5.1.1.
Market Estimation, 2015 - 2021
8.2.8.5.1.2.
Market Forecast, 2022 - 2030
8.2.8.5.2.
Europe
8.2.8.5.2.1.
Market Estimation, 2015 - 2021
8.2.8.5.2.2.
Market Forecast, 2022 - 2030
8.2.8.5.3.
Asia Pacific
8.2.8.5.3.1.
Market Estimation, 2015 - 2021
8.2.8.5.3.2.
Market Forecast, 2022 - 2030
8.2.8.5.4.
Middle East and Africa
8.2.8.5.4.1.
Market Estimation, 2015 - 2021
8.2.8.5.4.2.
Market Forecast, 2022 - 2030
8.2.8.5.5.
Latin America
8.2.8.5.5.1.
Market Estimation, 2015 - 2021
8.2.8.5.5.2.
Market Forecast, 2022 - 2030
8.3. Key Segment
for Channeling Investments
8.3.1.
By Clinical Indication
9.
Global I.V. Cannula
Market Analysis and Forecasts, 2022 - 2030
9.1. Overview
9.2.
Global I.V. Cannula
Market Revenue (US$ Mn) and Forecasts, By Type
9.2.1.
Wing/Butterfly
9.2.1.1.
Definition
9.2.1.2.
Market Estimation and Penetration,
2015 - 2021
9.2.1.3.
Market Forecast, 2022 - 2030
9.2.1.4.
Compound Annual Growth Rate (CAGR)
9.2.1.5.
Regional Bifurcation
9.2.1.5.1.
North America
9.2.1.5.1.1.
Market Estimation, 2015 - 2021
9.2.1.5.1.2.
Market Forecast, 2022 - 2030
9.2.1.5.2.
Europe
9.2.1.5.2.1.
Market Estimation, 2015 - 2021
9.2.1.5.2.2.
Market Forecast, 2022 - 2030
9.2.1.5.3.
Asia Pacific
9.2.1.5.3.1.
Market Estimation, 2015 - 2021
9.2.1.5.3.2.
Market Forecast, 2022 - 2030
9.2.1.5.4.
Middle East and Africa
9.2.1.5.4.1.
Market Estimation, 2015 - 2021
9.2.1.5.4.2.
Market Forecast, 2022 - 2030
9.2.1.5.5.
Latin America
9.2.1.5.5.1.
Market Estimation, 2015 - 2021
9.2.1.5.5.2.
Market Forecast, 2022 - 2030
9.2.2.
Pen/Straight
9.2.2.1.
Definition
9.2.2.2.
Market Estimation and Penetration, 2015 - 2021
9.2.2.3.
Market Forecast, 2022 - 2030
9.2.2.4.
Compound Annual Growth Rate (CAGR)
9.2.2.5.
Regional Bifurcation
9.2.2.5.1.
North America
9.2.2.5.1.1.
Market Estimation, 2015 - 2021
9.2.2.5.1.2.
Market Forecast, 2022 - 2030
9.2.2.5.2.
Europe
9.2.2.5.2.1.
Market Estimation, 2015 - 2021
9.2.2.5.2.2.
Market Forecast, 2022 - 2030
9.2.2.5.3.
Asia Pacific
9.2.2.5.3.1.
Market Estimation, 2015 - 2021
9.2.2.5.3.2.
Market Forecast, 2022 - 2030
9.2.2.5.4.
Middle East and Africa
9.2.2.5.4.1.
Market Estimation, 2015 - 2021
9.2.2.5.4.2.
Market Forecast, 2022 - 2030
9.2.2.5.5.
Latin America
9.2.2.5.5.1.
Market Estimation, 2015 - 2021
9.2.2.5.5.2.
Market Forecast, 2022 - 2030
9.2.3.
Y-type
9.2.3.1.
Definition
9.2.3.2.
Market Estimation and Penetration, 2015 - 2021
9.2.3.3.
Market Forecast, 2022 - 2030
9.2.3.4.
Compound Annual Growth Rate (CAGR)
9.2.3.5.
Regional Bifurcation
9.2.3.5.1.
North America
9.2.3.5.1.1.
Market Estimation, 2015 - 2021
9.2.3.5.1.2.
Market Forecast, 2022 - 2030
9.2.3.5.2.
Europe
9.2.3.5.2.1.
Market Estimation, 2015 - 2021
9.2.3.5.2.2.
Market Forecast, 2022 - 2030
9.2.3.5.3.
Asia Pacific
9.2.3.5.3.1.
Market Estimation, 2015 - 2021
9.2.3.5.3.2.
Market Forecast, 2022 - 2030
9.2.3.5.4.
Middle East and Africa
9.2.3.5.4.1.
Market Estimation, 2015 - 2021
9.2.3.5.4.2.
Market Forecast, 2022 - 2030
9.2.3.5.5.
Latin America
9.2.3.5.5.1.
Market Estimation, 2015 - 2021
9.2.3.5.5.2.
Market Forecast, 2022 - 2030
9.2.4.
Scalp-Type
9.2.4.1.
Definition
9.2.4.2.
Market Estimation and Penetration, 2015 - 2021
9.2.4.3.
Market Forecast, 2022 - 2030
9.2.4.4.
Compound Annual Growth Rate (CAGR)
9.2.4.5.
Regional Bifurcation
9.2.4.5.1.
North America
9.2.4.5.1.1.
Market Estimation, 2015 - 2021
9.2.4.5.1.2.
Market Forecast, 2022 - 2030
9.2.4.5.2.
Europe
9.2.4.5.2.1.
Market Estimation, 2015 - 2021
9.2.4.5.2.2.
Market Forecast, 2022 - 2030
9.2.4.5.3.
Asia Pacific
9.2.4.5.3.1.
Market Estimation, 2015 - 2021
9.2.4.5.3.2.
Market Forecast, 2022 - 2030
9.2.4.5.4.
Middle East and Africa
9.2.4.5.4.1.
Market Estimation, 2015 - 2021
9.2.4.5.4.2.
Market Forecast, 2022 - 2030
9.2.4.5.5.
Latin America
9.2.4.5.5.1.
Market Estimation, 2015 - 2021
9.2.4.5.5.2.
Market Forecast, 2022 - 2030
9.2.5.
Injection-Port Type
9.2.5.1.
Definition
9.2.5.2.
Market Estimation and Penetration, 2015 - 2021
9.2.5.3.
Market Forecast, 2022 - 2030
9.2.5.4.
Compound Annual Growth Rate (CAGR)
9.2.5.5.
Regional Bifurcation
9.2.5.5.1.
North America
9.2.5.5.1.1.
Market Estimation, 2015 - 2021
9.2.5.5.1.2.
Market Forecast, 2022 - 2030
9.2.5.5.2.
Europe
9.2.5.5.2.1.
Market Estimation, 2015 - 2021
9.2.5.5.2.2.
Market Forecast, 2022 - 2030
9.2.5.5.3.
Asia Pacific
9.2.5.5.3.1.
Market Estimation, 2015 - 2021
9.2.5.5.3.2.
Market Forecast, 2022 - 2030
9.2.5.5.4.
Middle East and Africa
9.2.5.5.4.1.
Market Estimation, 2015 - 2021
9.2.5.5.4.2.
Market Forecast, 2022 - 2030
9.2.5.5.5.
Latin America
9.2.5.5.5.1.
Market Estimation, 2015 - 2021
9.2.5.5.5.2.
Market Forecast, 2022 - 2030
9.2.6.
Others
9.2.6.1.
Definition
9.2.6.2.
Market Estimation and Penetration, 2015 - 2021
9.2.6.3.
Market Forecast, 2022 - 2030
9.2.6.4.
Compound Annual Growth
Rate (CAGR)
9.2.6.5.
Regional Bifurcation
9.2.6.5.1.
North America
9.2.6.5.1.1.
Market Estimation, 2015 - 2021
9.2.6.5.1.2.
Market Forecast, 2022 - 2030
9.2.6.5.2.
Europe
9.2.6.5.2.1.
Market Estimation, 2015 - 2021
9.2.6.5.2.2.
Market Forecast, 2022 - 2030
9.2.6.5.3.
Asia Pacific
9.2.6.5.3.1.
Market Estimation, 2015 - 2021
9.2.6.5.3.2.
Market Forecast, 2022 - 2030
9.2.6.5.4.
Middle East and Africa
9.2.6.5.4.1.
Market Estimation, 2015 - 2021
9.2.6.5.4.2.
Market Forecast, 2022 - 2030
9.2.6.5.5.
Latin America
9.2.6.5.5.1.
Market Estimation, 2015 - 2021
9.2.6.5.5.2.
Market Forecast, 2022 - 2030
9.3. Key Segment
for Channeling Investments
9.3.1.
By Type
10.
Global I.V. Cannula
Market Analysis and Forecasts, 2022 - 2030
10.1.
Overview
10.2.
Global I.V. Cannula
Market Revenue (US$ Mn) and Forecasts, By Needle
Type
10.2.1. 14 to 20 G
10.2.1.1.
Definition
10.2.1.2.
Market Estimation and Penetration, 2015 - 2021
10.2.1.3.
Market Forecast, 2022 - 2030
10.2.1.4.
Compound Annual Growth
Rate (CAGR)
10.2.1.5.
Regional Bifurcation
10.2.1.5.1.
North America
10.2.1.5.1.1. Market Estimation, 2015 - 2021
10.2.1.5.1.2. Market Forecast,
2022 - 2030
10.2.1.5.2.
Europe
10.2.1.5.2.1. Market Estimation, 2015 - 2021
10.2.1.5.2.2. Market Forecast, 2022 - 2030
10.2.1.5.3.
Asia Pacific
10.2.1.5.3.1. Market Estimation, 2015 - 2021
10.2.1.5.3.2. Market
Forecast, 2022 - 2030 10.2.1.5.4. Middle
East and Africa
10.2.1.5.4.1. Market Estimation, 2015 - 2021
10.2.1.5.4.2. Market Forecast,
2022 - 2030
10.2.1.5.5.
Latin America
10.2.1.5.5.1. Market Estimation, 2015 - 2021
10.2.1.5.5.2. Market Forecast,
2022 - 2030
10.2.2. 20 to 29 G
10.2.2.1.
Definition
10.2.2.2.
Market Estimation and Penetration, 2015 - 2021
10.2.2.3.
Market Forecast, 2022 - 2030
10.2.2.4.
Compound Annual Growth Rate (CAGR)
10.2.2.5.
Regional Bifurcation
10.2.2.5.1.
North America
10.2.2.5.1.1. Market Estimation, 2015 - 2021
10.2.2.5.1.2. Market Forecast,
2022 - 2030
10.2.2.5.2.
Europe
10.2.2.5.2.1. Market Estimation, 2015 - 2021
10.2.2.5.2.2. Market Forecast, 2022 - 2030
10.2.2.5.3.
Asia Pacific
10.2.2.5.3.1. Market Estimation, 2015 - 2021
10.2.2.5.3.2. Market
Forecast, 2022 - 2030 10.2.2.5.4. Middle
East and Africa
10.2.2.5.4.1. Market Estimation, 2015 - 2021
10.2.2.5.4.2. Market Forecast,
2022 - 2030
10.2.2.5.5.
Latin America
10.2.2.5.5.1.
Market Estimation, 2015 - 2021
10.2.2.5.5.2.
Market Forecast, 2022 - 2030
10.2.3.
Others
10.2.3.1.
Definition
10.2.3.2.
Market Estimation and Penetration, 2015 - 2021
10.2.3.3.
Market Forecast, 2022 - 2030
10.2.3.4.
Compound Annual Growth Rate (CAGR)
10.2.3.5.
Regional Bifurcation
10.2.3.5.1.
North America
10.2.3.5.1.1.
Market Estimation, 2015 - 2021
10.2.3.5.1.2.
Market Forecast, 2022 - 2030
10.2.3.5.2.
Europe
10.2.3.5.2.1.
Market Estimation, 2015 - 2021
10.2.3.5.2.2.
Market Forecast, 2022 - 2030
10.2.3.5.3.
Asia Pacific
10.2.3.5.3.1.
Market Estimation, 2015 - 2021
10.2.3.5.3.2.
Market Forecast, 2022 - 2030 10.2.3.5.4. Middle East and Africa
10.2.3.5.4.1.
Market Estimation, 2015 - 2021
10.2.3.5.4.2.
Market Forecast, 2022 - 2030
10.2.3.5.5.
Latin America
10.2.3.5.5.1.
Market Estimation, 2015 - 2021
10.2.3.5.5.2.
Market Forecast, 2022 - 2030
10.3. Key Segment
for Channeling Investments
10.3.1. By Needle Type
11.
Global I.V. Cannula
Market Analysis and Forecasts, 2022 - 2030
11.1.
Overview
11.2.
Global I.V. Cannula
Market Revenue (US$ Mn) and Forecasts, By End User
11.2.1.
Hospital
11.2.1.1.
Definition
11.2.1.2.
Market Estimation and Penetration, 2015 - 2021
11.2.1.3.
Market Forecast, 2022 - 2030
11.2.1.4.
Compound Annual Growth Rate (CAGR)
11.2.1.5.
Regional Bifurcation
11.2.1.5.1.
North America
11.2.1.5.1.1.
Market Estimation, 2015 - 2021
11.2.1.5.1.2.
Market Forecast, 2022 - 2030
11.2.1.5.2.
Europe
11.2.1.5.2.1.
Market Estimation, 2015 - 2021
11.2.1.5.2.2.
Market Forecast, 2022 - 2030
11.2.1.5.3.
Asia Pacific
11.2.1.5.3.1.
Market Estimation, 2015 - 2021
11.2.2. Clinics
11.2.2.1.1.1.
Market Forecast, 2022 - 2030 11.2.1.5.4. Middle East and Africa
11.2.1.5.4.1.
Market Estimation, 2015 - 2021
11.2.1.5.4.2.
Market Forecast, 2022 - 2030
11.2.1.5.5.
Latin America
11.2.1.5.5.1.
Market Estimation, 2015 - 2021
11.2.1.5.5.2.
Market Forecast, 2022 - 2030
11.2.2.2.
Definition
11.2.2.3.
Market Estimation and Penetration, 2015 - 2021
11.2.2.4.
Market Forecast, 2022 - 2030
11.2.2.5.
Compound Annual Growth Rate (CAGR)
11.2.2.6.
Regional Bifurcation
11.2.2.6.1.
North America
11.2.2.6.1.1.
Market Estimation, 2015 - 2021
11.2.2.6.1.2.
Market Forecast, 2022 - 2030
11.2.2.6.2.
Europe
11.2.2.6.2.1.
Market Estimation, 2015 - 2021
11.2.2.6.2.2.
Market Forecast, 2022 - 2030
11.2.2.6.3.
Asia Pacific
11.2.2.6.3.1.
Market Estimation, 2015 - 2021
11.2.2.6.3.2.
Market Forecast, 2022 - 2030 11.2.2.5.4. Middle East and Africa
11.2.2.5.4.1.
Market Estimation, 2015 - 2021
11.2.2.5.4.2.
Market Forecast, 2022 - 2030
11.2.2.5.5.
Latin America
11.2.2.5.5.1.
Market Estimation, 2015 - 2021
11.2.2.5.5.2.
Market Forecast, 2022 - 2030
11.2.3.
Ambulatory Surgical Centers
11.2.3.1.
Definition
11.2.3.2.
Market Estimation and Penetration, 2015 - 2021
11.2.3.3.
Market Forecast, 2022 - 2030
11.2.3.4.
Compound Annual Growth Rate (CAGR)
11.2.3.5.
Regional Bifurcation
11.2.3.5.1.
North America
11.2.3.5.1.1.
Market Estimation, 2015 - 2021
11.2.3.5.1.2.
Market Forecast, 2022 - 2030
11.2.3.5.2.
Europe
11.2.3.5.2.1.
Market Estimation, 2015 - 2021
11.2.3.5.2.2.
Market Forecast, 2022 - 2030
11.2.3.5.3.
Asia Pacific
11.2.3.5.3.1.
Market Estimation, 2015 - 2021
11.2.3.5.3.2.
Market Forecast, 2022 - 2030 11.2.3.5.4. Middle East and Africa
11.2.3.5.4.1.
Market Estimation, 2015 - 2021
11.2.3.5.4.2.
Market Forecast, 2022 - 2030
11.2.3.5.5.
Latin America
11.2.3.5.5.1.
Market Estimation, 2015 - 2021
11.2.3.5.5.2.
Market Forecast, 2022 - 2030
11.2.4.
Others
11.2.4.1.
Definition
11.2.4.2.
Market Estimation and Penetration, 2015 - 2021
11.2.4.3.
Market Forecast, 2022 - 2030
11.2.4.4.
Compound Annual Growth Rate (CAGR)
11.2.4.5.
Regional Bifurcation
11.2.4.5.1.
North America
11.2.4.5.1.1.
Market Estimation, 2015 - 2021
11.2.4.5.1.2.
Market Forecast, 2022 - 2030
11.2.4.5.2.
Europe
11.2.4.5.2.1.
Market Estimation, 2015 - 2021
11.2.4.5.2.2.
Market Forecast, 2022 - 2030
11.2.4.5.3.
Asia Pacific
11.2.4.5.3.1.
Market Estimation, 2015 - 2021
11.2.4.5.3.2.
Market Forecast, 2022 - 2030 11.2.4.5.4. Middle East and Africa
11.2.4.5.4.1.
Market Estimation, 2015 - 2021
11.2.4.5.4.2.
Market Forecast, 2022 - 2030
11.2.4.5.5.
Latin America
11.2.4.5.5.1.
Market Estimation, 2015 - 2021
11.2.4.5.5.2.
Market Forecast, 2022 - 2030
11.3. Key Segment
for Channeling Investments
11.3.1. By End User
12.
North America I.V. Cannula Market Analysis and Forecasts, 2022 - 2030
12.1.
Overview
12.1.1.
North America I.V. Cannula Market
Revenue (US$ Mn)
12.2.
North America I.V. Cannula
Market Revenue (US$ Mn) and Forecasts, By Clinical Indication
12.2.1.
Dehydration
12.2.2.
Nutrition
12.2.3. Shock
12.2.4.
Surgery
12.2.5. Blood Transfusions
12.2.6.
Chemotherapy
12.2.7.
Medication Administration
12.2.8.
Others
12.3.
North America I.V. Cannula
Market Revenue (US$ Mn) and Forecasts, By Type
12.3.1.
Wing/Butterfly
12.3.2.
Pen/Straight
12.3.3. Y-type
12.3.4.
Scalp-Type
12.3.5. Injection-Port Type
12.3.6.
Others
12.4.
North America I.V. Cannula
Market Revenue (US$ Mn) and Forecasts, By Needle Type
12.4.1. 14 to 20 G
12.4.2. 20 to 29 G
12.4.3.
Others
12.5.
North America I.V. Cannula Market
Revenue (US$ Mn) and Forecasts, By End User
12.5.1.
Hospital
12.5.2.
Clinics
12.5.3.
Ambulatory Surgical Centers
12.5.4.
Others
12.6.
North America I.V. Cannula Market Revenue (US$ Mn) and Forecasts, By Country
12.6.1. U.S
12.6.1.1.
U.S I.V. Cannula Market Revenue (US$ Mn) and
Forecasts, By Clinical Indication
12.6.1.1.1.
Dehydration
12.6.1.1.2.
Nutrition
12.6.1.1.3.
Shock
12.6.1.1.4.
Surgery
12.6.1.1.5.
Blood Transfusions
12.6.1.1.6.
Chemotherapy
12.6.1.1.7.
Medication Administration
12.6.1.1.8.
Others
12.6.1.2.
U.S I.V. Cannula Market Revenue (US$ Mn) and
Forecasts, By Type 12.6.1.2.1. Wing/Butterfly
12.6.1.2.2.
Pen/Straight
12.6.1.2.3.
Y-type
12.6.1.2.4.
Scalp-Type
12.6.1.2.5.
Injection-Port Type
12.6.1.2.6.
Others
12.6.1.3.
U.S I.V. Cannula Market Revenue (US$ Mn) and
Forecasts, By Needle Type
12.6.1.3.1. 14 to 20 G
12.6.1.3.2. 20 to 29 G
12.6.1.3.3. Others
12.6.1.4.
U.S I.V. Cannula Market Revenue (US$ Mn) and
Forecasts, By End User 12.6.1.4.1. Hospital
12.6.1.4.2.
Clinics
12.6.1.4.3.
Ambulatory Surgical Centers 12.6.1.4.4. Others
12.6.2. Canada
12.6.2.1.
Canada I.V. Cannula Market Revenue (US$ Mn) and
Forecasts, By Clinical Indication
12.6.2.1.1.
Dehydration
12.6.2.1.2.
Nutrition
12.6.2.1.3.
Shock
12.6.2.1.4.
Surgery
12.6.2.1.5.
Blood Transfusions
12.6.2.1.6.
Chemotherapy
12.6.2.1.7.
Medication Administration
12.6.2.1.8.
Others
12.6.2.2.
Canada I.V. Cannula Market Revenue (US$ Mn) and
Forecasts, By Type 12.6.2.2.1. Wing/Butterfly
12.6.2.2.2.
Pen/Straight
12.6.2.2.3.
Y-type
12.6.2.2.4.
Scalp-Type
12.6.2.2.5.
Injection-Port Type
12.6.2.2.6.
Others
12.6.2.3.
Canada I.V. Cannula Market Revenue (US$ Mn) and
Forecasts, By Needle Type
12.6.2.3.1. 14 to 20 G
12.6.2.3.2. 20 to 29 G
12.6.2.3.3. Others
12.6.2.4.
Canada I.V. Cannula Market Revenue (US$ Mn) and
Forecasts, By End User
12.6.2.4.1.
Hospital
12.6.2.4.2.
Clinics
12.6.2.4.3.
Ambulatory Surgical Centers
12.6.2.4.4.
Others
12.6.3.
Mexico
12.6.3.1.
Mexico I.V. Cannula Market Revenue (US$ Mn) and
Forecasts, By Clinical Indication
12.6.3.1.1.
Dehydration
12.6.3.1.2.
Nutrition
12.6.3.1.3.
Shock
12.6.3.1.4.
Surgery
12.6.3.1.5.
Blood Transfusions
12.6.3.1.6.
Chemotherapy
12.6.3.1.7.
Medication Administration
12.6.3.1.8.
Others
12.6.3.2.
Mexico I.V. Cannula Market Revenue (US$ Mn) and
Forecasts, By Type 12.6.3.2.1. Wing/Butterfly
12.6.3.2.2.
Pen/Straight
12.6.3.2.3.
Y-type
12.6.3.2.4.
Scalp-Type
12.6.3.2.5.
Injection-Port Type
12.6.3.2.6.
Others
12.6.3.3.
Mexico I.V. Cannula Market Revenue (US$ Mn) and
Forecasts, By Needle Type
12.6.3.3.1. 14 to 20 G
12.6.3.3.2. 20 to 29 G
12.6.3.3.3. Others
12.6.3.4.
Mexico I.V. Cannula Market Revenue (US$ Mn) and
Forecasts, By End User
12.6.3.4.1.
Hospital
12.6.3.4.2.
Clinics
12.6.3.4.3.
Ambulatory Surgical Centers 12.6.3.4.4. Others
12.6.4. Rest of North America
12.6.4.1.
Rest of North America I.V. Cannula Market Revenue (US$
Mn) and Forecasts, By Clinical
Indication
12.6.4.1.1.
Dehydration
12.6.4.1.2.
Nutrition
12.6.4.1.3.
Shock
12.6.4.1.4.
Surgery
12.6.4.1.5.
Blood Transfusions
12.6.4.1.6.
Chemotherapy
12.6.4.1.7.
Medication Administration
12.6.4.1.8.
Others
12.6.4.2.
Rest of North America I.V. Cannula Market Revenue (US$
Mn) and Forecasts, By Type
12.6.4.2.1.
Wing/Butterfly
12.6.4.2.2.
Pen/Straight
12.6.4.2.3.
Y-type
12.6.4.2.4.
Scalp-Type
12.6.4.2.5.
Injection-Port Type
12.6.4.2.6.
Others
12.6.4.3.
Rest of North America I.V. Cannula Market Revenue (US$
Mn) and Forecasts, By Needle Type
12.6.4.3.1. 14 to 20 G
12.6.4.3.2. 20 to 29 G
12.6.4.3.3. Others
12.6.4.4.
Rest of North America I.V. Cannula Market Revenue (US$
Mn) and Forecasts, By End User
12.6.4.4.1.
Hospital
12.6.4.4.2.
Clinics
12.6.4.4.3.
Ambulatory Surgical Centers 12.6.4.4.4. Others
12.7.
Key Segment for Channeling Investments
12.7.1.
By Country
12.7.2. By Clinical Indication
12.7.3.
By Type
12.7.4.
By Needle Type
12.7.5.
By End User
13.
Europe I.V. Cannula
Market Analysis and Forecasts, 2022 - 2030
13.1.
Overview
13.1.1.
Europe I.V. Cannula
Market Revenue (US$ Mn)
13.2.
Europe I.V. Cannula
Market Revenue (US$ Mn)
and Forecasts, By Clinical Indication
13.2.1.
Dehydration
13.2.2. Nutrition
13.2.3.
Shock
13.2.4. Surgery
13.2.5.
Blood Transfusions
13.2.6.
Chemotherapy
13.2.7.
Medication Administration
13.2.8. Others
13.3.
Europe I.V. Cannula
Market Revenue (US$ Mn)
and Forecasts, By Type
13.3.1. Wing/Butterfly
13.3.2.
Pen/Straight
13.3.3. Y-type
13.3.4.
Scalp-Type
13.3.5.
Injection-Port Type
13.3.6.
Others
13.4.
Europe I.V. Cannula
Market Revenue (US$ Mn)
and Forecasts, By Needle Type
13.4.1. 14 to 20 G
13.4.2. 20 to 29 G
13.4.3.
Others
13.5.
Europe I.V. Cannula
Market Revenue (US$ Mn)
and Forecasts, By End User
13.5.1. Hospital
13.5.2.
Clinics
13.5.3. Ambulatory Surgical
Centers
13.5.4.
Others
13.6.
Europe I.V. Cannula
Market Revenue (US$ Mn)
and Forecasts, By Country
13.6.1.
France
13.6.1.1.
France I.V. Cannula Market Revenue (US$ Mn) and
Forecasts, By Clinical Indication
13.6.1.1.1.
Dehydration
13.6.1.1.2.
Nutrition
13.6.1.1.3.
Shock
13.6.1.1.4.
Surgery
13.6.1.1.5.
Blood Transfusions
13.6.1.1.6.
Chemotherapy
13.6.1.1.7.
Medication Administration
13.6.1.1.8.
Others
13.6.1.2.
France I.V. Cannula Market Revenue (US$ Mn) and
Forecasts, By Type 13.6.1.2.1. Wing/Butterfly
13.6.1.2.2.
Pen/Straight
13.6.1.2.3.
Y-type
13.6.1.2.4.
Scalp-Type
13.6.1.2.5.
Injection-Port Type
13.6.1.2.6.
Others
13.6.1.3.
France I.V. Cannula Market Revenue (US$ Mn) and
Forecasts, By Needle Type
13.6.1.3.1. 14 to 20 G
13.6.1.3.2. 20 to 29 G
13.6.1.3.3. Others
13.6.1.4.
France I.V. Cannula Market Revenue (US$ Mn) and
Forecasts, By End User
13.6.1.4.1.
Hospital
13.6.1.4.2.
Clinics
13.6.1.4.3.
Ambulatory Surgical Centers 13.6.1.4.4. Others
13.6.2. The UK
13.6.2.1.
The UK I.V. Cannula Market Revenue (US$ Mn) and
Forecasts, By Clinical Indication
13.6.2.1.1.
Dehydration
13.6.2.1.2.
Nutrition
13.6.2.1.3.
Shock
13.6.2.1.4.
Surgery
13.6.2.1.5.
Blood Transfusions
13.6.2.1.6.
Chemotherapy
13.6.2.1.7.
Medication Administration
13.6.2.1.8.
Others
13.6.2.2.
The UK I.V. Cannula Market Revenue (US$ Mn) and
Forecasts, By Type 13.6.2.2.1. Wing/Butterfly
13.6.2.2.2.
Pen/Straight
13.6.2.2.3.
Y-type
13.6.2.2.4.
Scalp-Type
13.6.2.2.5.
Injection-Port Type
13.6.2.2.6.
Others
13.6.2.3.
The UK I.V. Cannula Market Revenue (US$ Mn) and
Forecasts, By Needle Type
13.6.2.3.1. 14 to 20 G
13.6.2.3.2. 20 to 29 G
13.6.2.3.3. Others
13.6.2.4.
The UK I.V. Cannula Market Revenue (US$ Mn) and
Forecasts, By End User
13.6.2.4.1.
Hospital
13.6.2.4.2.
Clinics
13.6.2.4.3.
Ambulatory Surgical Centers 13.6.2.4.4. Others
13.6.3.
Spain
13.6.3.1.
Spain I.V. Cannula Market Revenue (US$ Mn) and
Forecasts, By Clinical Indication
13.6.3.1.1.
Dehydration
13.6.3.1.2.
Nutrition
13.6.3.1.3.
Shock
13.6.3.1.4.
Surgery
13.6.3.1.5.
Blood Transfusions
13.6.3.1.6.
Chemotherapy
13.6.3.1.7.
Medication Administration
13.6.3.1.8.
Others
13.6.3.2.
Spain I.V. Cannula Market Revenue (US$ Mn) and
Forecasts, By Type 13.6.3.2.1. Wing/Butterfly
13.6.3.2.2.
Pen/Straight
13.6.3.2.3.
Y-type
13.6.3.2.4.
Scalp-Type
13.6.3.2.5.
Injection-Port Type
13.6.3.2.6.
Others
13.6.3.3.
Spain I.V. Cannula Market Revenue (US$ Mn) and
Forecasts, By Needle Type
13.6.3.3.1. 14 to 20 G
13.6.3.3.2. 20 to 29 G
13.6.3.3.3. Others
13.6.3.4.
Spain I.V. Cannula Market Revenue (US$ Mn) and
Forecasts, By End User 13.6.3.4.1. Hospital
13.6.3.4.2.
Clinics
13.6.3.4.3.
Ambulatory Surgical Centers 13.6.3.4.4. Others
13.6.4. Germany
13.6.4.1.
Germany I.V. Cannula Market Revenue (US$ Mn) and
Forecasts, By Clinical Indication
13.6.4.1.1.
Dehydration
13.6.4.1.2.
Nutrition
13.6.4.1.3.
Shock
13.6.4.1.4.
Surgery
13.6.4.1.5.
Blood Transfusions
13.6.4.1.6.
Chemotherapy
13.6.4.1.7.
Medication Administration
13.6.4.1.8.
Others
13.6.4.2.
Germany I.V. Cannula Market Revenue (US$ Mn) and
Forecasts, By Type 13.6.4.2.1. Wing/Butterfly
13.6.4.2.2.
Pen/Straight
13.6.4.2.3.
Y-type
13.6.4.2.4.
Scalp-Type
13.6.4.2.5.
Injection-Port Type
13.6.4.2.6.
Others
13.6.4.3.
Germany I.V. Cannula Market Revenue (US$ Mn) and
Forecasts, By Needle Type
13.6.4.3.1. 14 to 20 G
13.6.4.3.2. 20 to 29 G
13.6.4.3.3. Others
13.6.4.4.
Germany I.V. Cannula Market Revenue (US$ Mn) and
Forecasts, By End User
13.6.4.4.1.
Hospital
13.6.4.4.2.
Clinics
13.6.4.4.3.
Ambulatory Surgical Centers 13.6.4.4.4. Others
13.6.5. Italy
13.6.5.1.
Italy I.V. Cannula Market Revenue (US$ Mn) and
Forecasts, By Clinical Indication
13.6.5.1.1.
Dehydration
13.6.5.1.2.
Nutrition
13.6.5.1.3.
Shock
13.6.5.1.4.
Surgery
13.6.5.1.5.
Blood Transfusions
13.6.5.1.6.
Chemotherapy
13.6.5.1.7.
Medication Administration
13.6.5.1.8.
Others
13.6.5.2.
Italy I.V. Cannula Market Revenue (US$ Mn) and
Forecasts, By Type 13.6.5.2.1. Wing/Butterfly
13.6.5.2.2.
Pen/Straight
13.6.5.2.3.
Y-type
13.6.5.2.4.
Scalp-Type
13.6.5.2.5.
Injection-Port Type
13.6.5.2.6.
Others
13.6.5.3.
Italy I.V. Cannula Market Revenue (US$ Mn) and
Forecasts, By Needle Type
13.6.5.3.1. 14 to 20 G
13.6.5.3.2. 20 to 29 G
13.6.5.3.3. Others
13.6.5.4.
Italy I.V. Cannula Market Revenue (US$ Mn) and
Forecasts, By End User 13.6.5.4.1. Hospital
13.6.5.4.2.
Clinics
13.6.5.4.3.
Ambulatory Surgical Centers
13.6.5.4.4.
Others
13.6.6.
Nordic Countries
13.6.6.1.
Nordic Countries I.V. Cannula Market Revenue (US$ Mn)
and Forecasts, By Clinical
Indication
13.6.6.1.1.
Dehydration
13.6.6.1.2.
Nutrition
13.6.6.1.3.
Shock
13.6.6.1.4.
Surgery
13.6.6.1.5.
Blood Transfusions
13.6.6.1.6.
Chemotherapy
13.6.6.1.7.
Medication Administration
13.6.6.1.8.
Others
13.6.6.2.
Nordic Countries I.V. Cannula Market Revenue (US$ Mn)
and Forecasts, By Type
13.6.6.2.1.
Wing/Butterfly
13.6.6.2.2.
Pen/Straight
13.6.6.2.3.
Y-type
13.6.6.2.4.
Scalp-Type
13.6.6.2.5.
Injection-Port Type
13.6.6.2.6.
Others
13.6.6.3.
Nordic Countries I.V. Cannula Market Revenue (US$ Mn)
and Forecasts, By Needle
Type
13.6.6.3.1. 14 to 20 G
13.6.6.3.2. 20 to 29 G
13.6.6.3.3. Others
13.6.6.4.
Nordic Countries I.V. Cannula Market Revenue (US$ Mn)
and Forecasts, By End User
13.6.6.4.1.
Hospital
13.6.6.4.2.
Clinics
13.6.6.4.3.
Ambulatory Surgical Centers 13.6.6.4.4. Others
13.6.6.5.
Nordic Countries I.V. Cannula Market Revenue (US$ Mn)
and Forecasts, By Country
13.6.6.5.1.
Denmark
13.6.6.5.2.
Finland
13.6.6.5.3.
Iceland
13.6.6.5.4.
Sweden
13.6.6.5.5.
Norway
13.6.7.
Benelux Union
13.6.7.1.
Benelux Union I.V. Cannula Market Revenue (US$ Mn) and
Forecasts, By Clinical Indication
13.6.7.1.1.
Dehydration
13.6.7.1.2.
Nutrition
13.6.7.1.3.
Shock
13.6.7.1.4.
Surgery
13.6.7.1.5.
Blood Transfusions
13.6.7.1.6.
Chemotherapy
13.6.7.1.7.
Medication Administration
13.6.7.1.8.
Others
13.6.7.2.
Benelux Union I.V. Cannula Market Revenue (US$ Mn) and
Forecasts, By Type
13.6.7.2.1.
Wing/Butterfly
13.6.7.2.2.
Pen/Straight
13.6.7.2.3.
Y-type
13.6.7.2.4.
Scalp-Type
13.6.7.2.5.
Injection-Port Type
13.6.7.2.6.
Others
13.6.7.3.
Benelux Union I.V. Cannula Market Revenue (US$ Mn) and
Forecasts, By Needle Type
13.6.7.3.1. 14 to 20 G
13.6.7.3.2. 20 to 29 G
13.6.7.3.3. Others
13.6.7.4.
Benelux Union I.V. Cannula Market Revenue (US$ Mn) and
Forecasts, By End User
13.6.7.4.1.
Hospital
13.6.7.4.2.
Clinics
13.6.7.4.3.
Ambulatory Surgical Centers 13.6.7.4.4. Others
13.6.7.5.
Benelux Union I.V. Cannula Market Revenue (US$ Mn) and
Forecasts, By Country
13.6.7.5.1.
Belgium
13.6.7.5.2.
The Netherlands
13.6.7.5.3.
Luxembourg
13.6.8.
Rest of Europe
13.6.8.1.
Rest of Europe I.V. Cannula Market Revenue (US$ Mn)
and Forecasts, By Clinical Indication
13.6.8.1.1.
Dehydration
13.6.8.1.2.
Nutrition
13.6.8.1.3.
Shock
13.6.8.1.4.
Surgery
13.6.8.1.5.
Blood Transfusions
13.6.8.1.6.
Chemotherapy
13.6.8.1.7.
Medication Administration
13.6.8.1.8.
Others
13.6.8.2.
Rest of Europe I.V. Cannula Market Revenue (US$ Mn)
and Forecasts, By Type
13.6.8.2.1.
Wing/Butterfly
13.6.8.2.2.
Pen/Straight
13.6.8.2.3.
Y-type
13.6.8.2.4.
Scalp-Type
13.6.8.2.5.
Injection-Port Type
13.6.8.2.6.
Others
13.6.8.3.
Rest of Europe I.V. Cannula Market Revenue (US$ Mn)
and Forecasts, By Needle Type
13.6.8.3.1. 14 to 20 G
13.6.8.3.2. 20 to 29 G
13.6.8.3.3. Others
13.6.8.4.
Rest of Europe I.V. Cannula Market Revenue (US$ Mn)
and Forecasts, By End User
13.6.8.4.1.
Hospital
13.6.8.4.2.
Clinics
13.6.8.4.3.
Ambulatory Surgical Centers 13.6.8.4.4. Others
13.7.
Key Segment for Channeling Investments
13.7.1.
By Country
13.7.2. By Clinical Indication
13.7.3.
By Type
13.7.4.
By Needle Type
13.7.5.
By End User
14.
Asia Pacific I.V. Cannula Market Analysis and Forecasts, 2022 - 2030
14.1.
Overview
14.1.1.
Asia Pacific I.V. Cannula Market
Revenue (US$ Mn)
14.2.
Asia Pacific I.V. Cannula Market
Revenue (US$ Mn) and Forecasts, By Clinical Indication
14.2.1.
Dehydration
14.2.2.
Nutrition
14.2.3.
Shock
14.2.4. Surgery
14.2.5.
Blood Transfusions
14.2.6. Chemotherapy
14.2.7.
Medication Administration
14.2.8. Others
14.3.
Asia Pacific I.V. Cannula Market
Revenue (US$ Mn) and Forecasts, By Type
14.3.1.
Wing/Butterfly
14.3.2.
Pen/Straight
14.3.3. Y-type
14.3.4.
Scalp-Type
14.3.5.
Injection-Port Type
14.3.6.
Others
14.4.
Asia Pacific I.V. Cannula Market
Revenue (US$ Mn) and Forecasts, By Needle Type
14.4.1. 14 to 20 G
14.4.2. 20 to 29 G
14.4.3.
Others
14.5.
Asia Pacific I.V. Cannula Market
Revenue (US$ Mn) and Forecasts, By End User
14.5.1.
Hospital
14.5.2.
Clinics
14.5.3. Ambulatory Surgical
Centers
14.5.4.
Others
14.6.
Asia Pacific I.V. Cannula Market
Revenue (US$ Mn) and Forecasts, By Country
14.6.1.
China
14.6.1.1.
China I.V. Cannula Market Revenue (US$ Mn) and
Forecasts, By Clinical Indication
14.6.1.1.1.
Dehydration
14.6.1.1.2.
Nutrition
14.6.1.1.3.
Shock
14.6.1.1.4.
Surgery
14.6.1.1.5.
Blood Transfusions
14.6.1.1.6.
Chemotherapy
14.6.1.1.7.
Medication Administration
14.6.1.1.8.
Others
14.6.1.2.
China I.V. Cannula Market Revenue (US$ Mn) and
Forecasts, By Type 14.6.1.2.1. Wing/Butterfly
14.6.1.2.2.
Pen/Straight
14.6.1.2.3.
Y-type
14.6.1.2.4.
Scalp-Type
14.6.1.2.5.
Injection-Port Type
14.6.1.2.6.
Others
14.6.1.3.
China I.V. Cannula Market Revenue (US$ Mn) and
Forecasts, By Needle Type
14.6.1.3.1. 14 to 20 G
14.6.1.3.2. 20 to 29 G
14.6.1.3.3. Others
14.6.1.4.
China I.V. Cannula Market Revenue (US$ Mn) and
Forecasts, By End User 14.6.1.4.1. Hospital
14.6.1.4.2.
Clinics
14.6.1.4.3.
Ambulatory Surgical Centers 14.6.1.4.4. Others
14.6.2. Japan
14.6.2.1.
Japan I.V. Cannula Market Revenue (US$ Mn) and
Forecasts, By Clinical Indication
14.6.2.1.1.
Dehydration
14.6.2.1.2.
Nutrition
14.6.2.1.3.
Shock
14.6.2.1.4.
Surgery
14.6.2.1.5.
Blood Transfusions
14.6.2.1.6.
Chemotherapy
14.6.2.1.7.
Medication Administration
14.6.2.1.8.
Others
14.6.2.2.
Japan I.V. Cannula Market Revenue (US$ Mn) and
Forecasts, By Type 14.6.2.2.1. Wing/Butterfly
14.6.2.2.2.
Pen/Straight
14.6.2.2.3.
Y-type
14.6.2.2.4.
Scalp-Type
14.6.2.2.5.
Injection-Port Type
14.6.2.2.6.
Others
14.6.2.3.
Japan I.V. Cannula Market Revenue (US$ Mn) and
Forecasts, By Needle Type
14.6.2.3.1. 14 to 20 G
14.6.2.3.2. 20 to 29 G
14.6.2.3.3. Others
14.6.2.4.
Japan I.V. Cannula Market Revenue (US$ Mn) and
Forecasts, By End User 14.6.2.4.1. Hospital
14.6.2.4.2.
Clinics
14.6.2.4.3.
Ambulatory Surgical Centers 14.6.2.4.4. Others
14.6.3. India
14.6.3.1.
India I.V. Cannula Market Revenue (US$ Mn) and
Forecasts, By Clinical Indication
14.6.3.1.1.
Dehydration
14.6.3.1.2.
Nutrition
14.6.3.1.3.
Shock
14.6.3.1.4.
Surgery
14.6.3.1.5.
Blood Transfusions
14.6.3.1.6.
Chemotherapy
14.6.3.1.7.
Medication Administration
14.6.3.1.8.
Others
14.6.3.2.
India I.V. Cannula Market Revenue (US$ Mn) and
Forecasts, By Type 14.6.3.2.1. Wing/Butterfly
14.6.3.2.2.
Pen/Straight
14.6.3.2.3.
Y-type
14.6.3.2.4.
Scalp-Type
14.6.3.2.5.
Injection-Port Type
14.6.3.2.6.
Others
14.6.3.3.
India I.V. Cannula Market Revenue (US$ Mn) and
Forecasts, By Needle Type
14.6.3.3.1. 14 to 20 G
14.6.3.3.2. 20 to 29 G
14.6.3.3.3. Others
14.6.3.4.
India I.V. Cannula Market Revenue (US$ Mn) and
Forecasts, By End User 14.6.3.4.1. Hospital
14.6.3.4.2.
Clinics
14.6.3.4.3.
Ambulatory Surgical Centers 14.6.3.4.4. Others
14.6.4. New Zealand
14.6.4.1.
New Zealand I.V. Cannula Market Revenue (US$ Mn) and
Forecasts, By Clinical Indication
14.6.4.1.1.
Dehydration
14.6.4.1.2.
Nutrition
14.6.4.1.3.
Shock
14.6.4.1.4.
Surgery
14.6.4.1.5.
Blood Transfusions
14.6.4.1.6.
Chemotherapy
14.6.4.1.7.
Medication Administration
14.6.4.1.8.
Others
14.6.4.2.
New Zealand I.V. Cannula Market Revenue (US$ Mn) and
Forecasts, By Type
14.6.4.2.1.
Wing/Butterfly
14.6.4.2.2.
Pen/Straight
14.6.4.2.3.
Y-type
14.6.4.2.4.
Scalp-Type
14.6.4.2.5.
Injection-Port Type
14.6.4.2.6.
Others
14.6.4.3.
New Zealand I.V. Cannula Market Revenue (US$ Mn) and Forecasts,
By Needle Type
14.6.4.3.1. 14 to 20 G
14.6.4.3.2. 20 to 29 G
14.6.4.3.3. Others
14.6.4.4.
New Zealand I.V. Cannula Market Revenue (US$ Mn) and
Forecasts, By End User
14.6.4.4.1.
Hospital
14.6.4.4.2.
Clinics
14.6.4.4.3.
Ambulatory Surgical Centers 14.6.4.4.4. Others
14.6.5. Australia
14.6.5.1.
Australia I.V. Cannula Market Revenue (US$ Mn) and
Forecasts, By Clinical Indication
14.6.5.1.1.
Dehydration
14.6.5.1.2.
Nutrition
14.6.5.1.3.
Shock
14.6.5.1.4.
Surgery
14.6.5.1.5.
Blood Transfusions
14.6.5.1.6.
Chemotherapy
14.6.5.1.7.
Medication Administration
14.6.5.1.8.
Others
14.6.5.2.
Australia I.V. Cannula Market Revenue (US$ Mn) and
Forecasts, By Type 14.6.5.2.1. Wing/Butterfly
14.6.5.2.2.
Pen/Straight
14.6.5.2.3.
Y-type
14.6.5.2.4.
Scalp-Type
14.6.5.2.5.
Injection-Port Type
14.6.5.2.6.
Others
14.6.5.3.
Australia I.V. Cannula Market Revenue (US$ Mn) and
Forecasts, By Needle Type
14.6.5.3.1. 14 to 20 G
14.6.5.3.2. 20 to 29 G
14.6.5.3.3. Others
14.6.5.4.
Australia I.V. Cannula Market Revenue (US$ Mn) and
Forecasts, By End User
14.6.5.4.1.
Hospital
14.6.5.4.2.
Clinics
14.6.5.4.3.
Ambulatory Surgical Centers 14.6.5.4.4. Others
14.6.6. South Korea
14.6.6.1.
South Korea I.V. Cannula Market Revenue (US$ Mn) and
Forecasts, By Clinical Indication
14.6.6.1.1.
Dehydration
14.6.6.1.2.
Nutrition
14.6.6.1.3.
Shock
14.6.6.1.4.
Surgery
14.6.6.1.5.
Blood Transfusions
14.6.6.1.6.
Chemotherapy
14.6.6.1.7.
Medication Administration
14.6.6.1.8.
Others
14.6.6.2.
South Korea I.V. Cannula Market Revenue (US$ Mn) and
Forecasts, By Type
14.6.6.2.1.
Wing/Butterfly
14.6.6.2.2.
Pen/Straight
14.6.6.2.3.
Y-type
14.6.6.2.4.
Scalp-Type
14.6.6.2.5.
Injection-Port Type
14.6.6.2.6.
Others
14.6.6.3.
South Korea I.V. Cannula Market Revenue (US$ Mn) and
Forecasts, By Needle Type
14.6.6.3.1. 14 to 20 G
14.6.6.3.2. 20 to 29 G
14.6.6.3.3. Others
14.6.6.4.
South Korea I.V. Cannula Market Revenue (US$ Mn) and
Forecasts, By End User
14.6.6.4.1.
Hospital
14.6.6.4.2.
Clinics
14.6.6.4.3.
Ambulatory Surgical Centers 14.6.6.4.4. Others
14.6.7. Southeast Asia
14.6.7.1.
Southeast Asia I.V. Cannula Market Revenue (US$ Mn)
and Forecasts, By Clinical Indication
14.6.7.1.1.
Dehydration
14.6.7.1.2.
Nutrition
14.6.7.1.3.
Shock
14.6.7.1.4.
Surgery
14.6.7.1.5.
Blood Transfusions
14.6.7.1.6.
Chemotherapy
14.6.7.1.7.
Medication Administration
14.6.7.1.8.
Others
14.6.7.2.
Southeast Asia I.V. Cannula Market Revenue (US$ Mn)
and Forecasts, By Type
14.6.7.2.1.
Wing/Butterfly
14.6.7.2.2.
Pen/Straight
14.6.7.2.3.
Y-type
14.6.7.2.4.
Scalp-Type
14.6.7.2.5.
Injection-Port Type
14.6.7.2.6.
Others
14.6.7.3.
Southeast Asia I.V. Cannula Market Revenue (US$ Mn)
and Forecasts, By Needle Type
14.6.7.3.1. 14 to 20 G
14.6.7.3.2. 20 to 29 G
14.6.7.3.3. Others
14.6.7.4.
Southeast Asia I.V. Cannula Market Revenue (US$ Mn)
and Forecasts, By End User
14.6.7.4.1.
Hospital
14.6.7.4.2.
Clinics
14.6.7.4.3.
Ambulatory Surgical Centers 14.6.7.4.4. Others
14.6.7.5.
Southeast Asia I.V. Cannula Market Revenue (US$ Mn)
and Forecasts, By Country
14.6.7.5.1.
Indonesia
14.6.7.5.2.
Thailand
14.6.7.5.3.
Malaysia
14.6.7.5.4.
Singapore
14.6.7.5.5.
Rest of Southeast Asia
14.6.8. Rest of Asia Pacific
14.6.8.1.
Rest of Asia Pacific I.V. Cannula Market Revenue (US$
Mn) and Forecasts, By Clinical
Indication
14.6.8.1.1.
Dehydration
14.6.8.1.2.
Nutrition
14.6.8.1.3.
Shock
14.6.8.1.4.
Surgery
14.6.8.1.5.
Blood Transfusions
14.6.8.1.6.
Chemotherapy
14.6.8.1.7.
Medication Administration
14.6.8.1.8.
Others
14.6.8.2.
Rest of Asia Pacific I.V. Cannula Market Revenue (US$
Mn) and Forecasts, By Type
14.6.8.2.1.
Wing/Butterfly
14.6.8.2.2.
Pen/Straight
14.6.8.2.3.
Y-type
14.6.8.2.4.
Scalp-Type
14.6.8.2.5.
Injection-Port Type
14.6.8.2.6.
Others
14.6.8.3.
Rest of Asia Pacific I.V. Cannula Market Revenue (US$
Mn) and Forecasts, By Needle
Type
14.6.8.3.1. 14 to 20 G
14.6.8.3.2. 20 to 29 G
14.6.8.3.3. Others
14.6.8.4.
Rest of Asia Pacific I.V. Cannula Market Revenue (US$
Mn) and Forecasts, By End User
14.6.8.4.1.
Hospital
14.6.8.4.2.
Clinics
14.6.8.4.3.
Ambulatory Surgical Centers 14.6.8.4.4. Others
14.7.
Key Segment for Channeling Investments
14.7.1.
By Country
14.7.2.
By Clinical Indication
14.7.3. By Type
14.7.4.
By Needle Type
14.7.5.
By End User
15.
Middle East and Africa I.V. Cannula Market Analysis and Forecasts, 2022 - 2030
15.1.
Overview
15.1.1. Middle East and Africa
I.V. Cannula Market
Revenue (US$ Mn)
15.2.
Middle East and Africa I.V. Cannula Market Revenue (US$
Mn) and Forecasts, By Clinical Indication
15.2.1. Dehydration
15.2.2. Nutrition
15.2.3. Shock
15.2.4.
Surgery
15.2.5.
Blood Transfusions
15.2.6.
Chemotherapy
15.2.7. Medication Administration
15.2.8.
Others
15.3.
Middle East and Africa I.V. Cannula
Market Revenue (US$ Mn) and Forecasts, By Type
15.3.1.
Wing/Butterfly
15.3.2.
Pen/Straight
15.3.3. Y-type
15.3.4. Scalp-Type
15.3.5.
Injection-Port Type
15.3.6.
Others
15.4.
Middle East and Africa I.V. Cannula Market Revenue
(US$ Mn) and Forecasts, By Needle Type
15.4.1. 14 to 20 G
15.4.2. 20 to 29 G
15.4.3.
Others
15.5.
Middle East and Africa I.V. Cannula
Market Revenue (US$ Mn) and Forecasts, By End User
15.5.1. Hospital
15.5.2.
Clinics
15.5.3.
Ambulatory Surgical Centers
15.5.4.
Others
15.6.
Middle East and Africa I.V. Cannula Market Revenue
(US$ Mn) and Forecasts, By Country
15.6.1. Saudi Arabia
15.6.1.1.
Saudi Arabia I.V. Cannula Market Revenue (US$ Mn) and
Forecasts, By Clinical Indication
15.6.1.1.1.
Dehydration
15.6.1.1.2.
Nutrition
15.6.1.1.3.
Shock
15.6.1.1.4.
Surgery
15.6.1.1.5.
Blood Transfusions
15.6.1.1.6.
Chemotherapy
15.6.1.1.7.
Medication Administration
15.6.1.1.8.
Others
15.6.1.2.
Saudi Arabia I.V. Cannula Market Revenue (US$ Mn) and
Forecasts, By Type
15.6.1.2.1.
Wing/Butterfly
15.6.1.2.2.
Pen/Straight
15.6.1.2.3.
Y-type
15.6.1.2.4.
Scalp-Type
15.6.1.2.5.
Injection-Port Type
15.6.1.2.6.
Others
15.6.1.3.
Saudi Arabia I.V. Cannula Market Revenue (US$ Mn) and
Forecasts, By Needle Type
15.6.1.3.1. 14 to 20 G
15.6.1.3.2. 20 to 29 G
15.6.1.3.3. Others
15.6.1.4.
Saudi Arabia I.V. Cannula Market Revenue (US$ Mn) and Forecasts,
By End User
15.6.1.4.1.
Hospital
15.6.1.4.2.
Clinics
15.6.1.4.3.
Ambulatory Surgical Centers 15.6.1.4.4. Others
15.6.2. UAE
15.6.2.1.
UAE I.V. Cannula Market Revenue (US$ Mn) and
Forecasts, By Clinical Indication
15.6.2.1.1.
Dehydration
15.6.2.1.2.
Nutrition
15.6.2.1.3.
Shock
15.6.2.1.4.
Surgery
15.6.2.1.5.
Blood Transfusions
15.6.2.1.6.
Chemotherapy
15.6.2.1.7.
Medication Administration
15.6.2.1.8.
Others
15.6.2.2.
UAE I.V. Cannula Market Revenue (US$ Mn) and
Forecasts, By Type 15.6.2.2.1. Wing/Butterfly
15.6.2.2.2.
Pen/Straight
15.6.2.2.3.
Y-type
15.6.2.2.4.
Scalp-Type
15.6.2.2.5.
Injection-Port Type
15.6.2.2.6.
Others
15.6.2.3.
UAE I.V. Cannula Market Revenue (US$ Mn) and
Forecasts, By Needle Type
15.6.2.3.1. 14 to 20 G
15.6.2.3.2. 20 to 29 G
15.6.2.3.3. Others
15.6.2.4.
UAE I.V. Cannula Market Revenue (US$ Mn) and
Forecasts, By End User 15.6.2.4.1. Hospital
15.6.2.4.2.
Clinics
15.6.2.4.3.
Ambulatory Surgical Centers 15.6.2.4.4. Others
15.6.3. Egypt
15.6.3.1.
Egypt I.V. Cannula Market Revenue (US$ Mn) and
Forecasts, By Clinical Indication
15.6.3.1.1.
Dehydration
15.6.3.1.2.
Nutrition
15.6.3.1.3.
Shock
15.6.3.1.4.
Surgery
15.6.3.1.5.
Blood Transfusions
15.6.3.1.6.
Chemotherapy
15.6.3.1.7.
Medication Administration
15.6.3.1.8.
Others
15.6.3.2.
Egypt I.V. Cannula Market Revenue (US$ Mn) and
Forecasts, By Type 15.6.3.2.1. Wing/Butterfly
15.6.3.2.2.
Pen/Straight
15.6.3.2.3.
Y-type
15.6.3.2.4.
Scalp-Type
15.6.3.2.5.
Injection-Port Type
15.6.3.2.6.
Others
15.6.3.3.
Egypt I.V. Cannula Market Revenue (US$ Mn) and
Forecasts, By Needle Type
15.6.3.3.1. 14 to 20 G
15.6.3.3.2. 20 to 29 G
15.6.3.3.3. Others
15.6.3.4.
Egypt I.V. Cannula Market Revenue (US$ Mn) and
Forecasts, By End User 15.6.3.4.1. Hospital
15.6.3.4.2.
Clinics
15.6.3.4.3.
Ambulatory Surgical Centers 15.6.3.4.4. Others
15.6.4. Kuwait
15.6.4.1.
Kuwait I.V. Cannula Market Revenue (US$ Mn) and
Forecasts, By Clinical Indication
15.6.4.1.1.
Dehydration
15.6.4.1.2.
Nutrition
15.6.4.1.3.
Shock
15.6.4.1.4.
Surgery
15.6.4.1.5.
Blood Transfusions
15.6.4.1.6.
Chemotherapy
15.6.4.1.7.
Medication Administration
15.6.4.1.8.
Others
15.6.4.2.
Kuwait I.V. Cannula Market
Revenue (US$ Mn) and Forecasts, By Type
15.6.4.2.1.
Wing/Butterfly
15.6.4.2.2.
Pen/Straight
15.6.4.2.3.
Y-type
15.6.4.2.4.
Scalp-Type
15.6.4.2.5.
Injection-Port Type
15.6.4.2.6.
Others
15.6.4.3.
Kuwait I.V. Cannula Market Revenue (US$ Mn) and
Forecasts, By Needle Type
15.6.4.3.1. 14 to 20 G
15.6.4.3.2. 20 to 29 G
15.6.4.3.3. Others
15.6.4.4.
Kuwait I.V. Cannula Market Revenue (US$ Mn) and
Forecasts, By End User
15.6.4.4.1.
Hospital
15.6.4.4.2.
Clinics
15.6.4.4.3.
Ambulatory Surgical Centers 15.6.4.4.4. Others
15.6.5. South Africa
15.6.5.1.
South Africa I.V. Cannula Market Revenue (US$ Mn) and
Forecasts, By Clinical Indication
15.6.5.1.1.
Dehydration
15.6.5.1.2.
Nutrition
15.6.5.1.3.
Shock
15.6.5.1.4.
Surgery
15.6.5.1.5.
Blood Transfusions
15.6.5.1.6.
Chemotherapy
15.6.5.1.7.
Medication Administration
15.6.5.1.8.
Others
15.6.5.2.
South Africa I.V. Cannula Market Revenue (US$ Mn) and
Forecasts, By Type
15.6.5.2.1.
Wing/Butterfly
15.6.5.2.2.
Pen/Straight
15.6.5.2.3.
Y-type
15.6.5.2.4.
Scalp-Type
15.6.5.2.5.
Injection-Port Type
15.6.5.2.6.
Others
15.6.5.3.
South Africa I.V. Cannula Market Revenue (US$ Mn) and
Forecasts, By Needle Type
15.6.5.3.1. 14 to 20 G
15.6.5.3.2. 20 to 29 G
15.6.5.3.3. Others
15.6.5.4.
South Africa I.V. Cannula Market Revenue (US$ Mn) and
Forecasts, By End User
15.6.5.4.1.
Hospital
15.6.5.4.2.
Clinics
15.6.5.4.3.
Ambulatory Surgical Centers 15.6.5.4.4. Others
15.6.6. Rest of Middle East & Africa
15.6.6.1.
Rest of Middle East & Africa I.V. Cannula Market
Revenue (US$ Mn) and Forecasts, By Clinical
Indication
15.6.6.1.1.
Dehydration
15.6.6.1.2.
Nutrition
15.6.6.1.3.
Shock
15.6.6.1.4.
Surgery
15.6.6.1.5.
Blood Transfusions
15.6.6.1.6.
Chemotherapy
15.6.6.1.7.
Medication Administration
15.6.6.1.8.
Others
15.6.6.2.
Rest of Middle East & Africa I.V. Cannula Market
Revenue (US$ Mn) and Forecasts, By Type
15.6.6.2.1.
Wing/Butterfly
15.6.6.2.2.
Pen/Straight
15.6.6.2.3.
Y-type
15.6.6.2.4.
Scalp-Type
15.6.6.2.5.
Injection-Port Type
15.6.6.2.6.
Others
15.6.6.3.
Rest of Middle East & Africa I.V. Cannula Market
Revenue (US$ Mn) and Forecasts, By Needle Type
15.6.6.3.1. 14 to 20 G
15.6.6.3.2. 20 to 29 G
15.6.6.3.3. Others
15.6.6.4.
Rest of Middle East & Africa I.V. Cannula Market
Revenue (US$ Mn) and Forecasts, By End User
15.6.6.4.1.
Hospital
15.6.6.4.2.
Clinics
15.6.6.4.3.
Ambulatory Surgical Centers 15.6.6.4.4. Others
15.7.
Key Segment for Channeling Investments
15.7.1.
By Country
15.7.2.
By Clinical Indication
15.7.3. By Type
15.7.4.
By Needle Type
15.7.5. By End User
16.
Latin America I.V. Cannula Market
Analysis and Forecasts, 2022 - 2030
16.1.
Overview
16.1.1.
Latin America I.V. Cannula Market
Revenue (US$ Mn)
16.2.
Latin America I.V. Cannula Market
Revenue (US$ Mn) and
Forecasts, By Clinical
Indication
16.2.1.
Dehydration
16.2.2.
Nutrition
16.2.3.
Shock
16.2.4.
Surgery
16.2.5. Blood Transfusions
16.2.6.
Chemotherapy
16.2.7. Medication Administration
16.2.8.
Others
16.3.
Latin America I.V. Cannula
Market Revenue (US$ Mn) and Forecasts, By Type
16.3.1.
Wing/Butterfly
16.3.2. Pen/Straight
16.3.3. Y-type
16.3.4.
Scalp-Type
16.3.5.
Injection-Port Type
16.3.6.
Others
16.4.
Latin America I.V. Cannula Market
Revenue (US$ Mn) and
Forecasts, By Needle
Type
16.4.1. 14 to 20 G
16.4.2. 20 to 29 G
16.4.3.
Others
16.5.
Latin America I.V. Cannula Market
Revenue (US$ Mn) and Forecasts, By End User
16.5.1.
Hospital
16.5.2.
Clinics
16.5.3. Ambulatory Surgical
Centers
16.5.4.
Others
16.6.
Latin America I.V. Cannula
Market Revenue (US$ Mn) and
Forecasts, By Country
16.6.1. Brazil
16.6.1.1.
Brazil I.V. Cannula Market Revenue (US$ Mn) and
Forecasts, By Clinical Indication
16.6.1.1.1.
Dehydration
16.6.1.1.2.
Nutrition
16.6.1.1.3.
Shock
16.6.1.1.4.
Surgery
16.6.1.1.5.
Blood Transfusions
16.6.1.1.6.
Chemotherapy
16.6.1.1.7.
Medication Administration
16.6.1.1.8.
Others
16.6.1.2.
Brazil I.V. Cannula Market Revenue (US$ Mn) and
Forecasts, By Type 16.6.1.2.1. Wing/Butterfly
16.6.1.2.2.
Pen/Straight
16.6.1.2.3.
Y-type
16.6.1.2.4.
Scalp-Type
16.6.1.2.5.
Injection-Port Type
16.6.1.2.6.
Others
16.6.1.3.
Brazil I.V. Cannula Market Revenue (US$ Mn) and
Forecasts, By Needle Type
16.6.1.3.1. 14 to 20 G
16.6.1.3.2. 20 to 29 G
16.6.1.3.3. Others
16.6.1.4.
Brazil I.V. Cannula Market Revenue (US$ Mn) and Forecasts,
By End User 16.6.1.4.1. Hospital
16.6.1.4.2.
Clinics
16.6.1.4.3.
Ambulatory Surgical Centers 16.6.1.4.4. Others
16.6.2. Argentina
16.6.2.1.
Argentina I.V. Cannula Market Revenue (US$ Mn) and
Forecasts, By Clinical Indication
16.6.2.1.1.
Dehydration
16.6.2.1.2.
Nutrition
16.6.2.1.3.
Shock
16.6.2.1.4.
Surgery
16.6.2.1.5.
Blood Transfusions
16.6.2.1.6.
Chemotherapy
16.6.2.1.7.
Medication Administration
16.6.2.1.8.
Others
16.6.2.2.
Argentina I.V. Cannula Market Revenue (US$ Mn) and
Forecasts, By Type 16.6.2.2.1. Wing/Butterfly
16.6.2.2.2.
Pen/Straight
16.6.2.2.3.
Y-type
16.6.2.2.4.
Scalp-Type
16.6.2.2.5.
Injection-Port Type
16.6.2.2.6.
Others
16.6.2.3.
Argentina I.V. Cannula Market Revenue (US$ Mn) and
Forecasts, By Needle Type
16.6.2.3.1. 14 to 20 G
16.6.2.3.2. 20 to 29 G
16.6.2.3.3. Others
16.6.2.4.
Argentina I.V. Cannula Market Revenue (US$ Mn) and
Forecasts, By End User
16.6.2.4.1.
Hospital
16.6.2.4.2.
Clinics
16.6.2.4.3.
Ambulatory Surgical Centers 16.6.2.4.4. Others
16.6.3. Rest of Latin America
16.6.3.1.
Rest of Latin America I.V. Cannula Market Revenue (US$
Mn) and Forecasts, By Clinical
Indication
16.6.3.1.1.
Dehydration
16.6.3.1.2.
Nutrition
16.6.3.1.3.
Shock
16.6.3.1.4.
Surgery
16.6.3.1.5.
Blood Transfusions
16.6.3.1.6.
Chemotherapy
16.6.3.1.7.
Medication Administration
16.6.3.1.8.
Others
16.6.3.2.
Rest of Latin America I.V. Cannula Market Revenue (US$
Mn) and Forecasts, By Type
16.6.3.2.1.
Wing/Butterfly
16.6.3.2.2.
Pen/Straight
16.6.3.2.3.
Y-type
16.6.3.2.4.
Scalp-Type
16.6.3.2.5.
Injection-Port Type
16.6.3.2.6.
Others
16.6.3.3.
Rest of Latin America I.V. Cannula Market Revenue (US$
Mn) and Forecasts, By Needle Type
16.6.3.3.1. 14 to 20 G
16.6.3.3.2. 20 to 29 G
16.6.3.3.3. Others
16.6.3.4.
Rest of Latin America I.V. Cannula Market Revenue (US$
Mn) and Forecasts, By End User
16.6.3.4.1.
Hospital
16.6.3.4.2.
Clinics
16.6.3.4.3.
Ambulatory Surgical Centers
16.6.3.4.4.
Others
16.7.
Key Segment for Channeling Investments
16.7.1. By Country
16.7.2.
By Clinical Indication
16.7.3.
By Type
16.7.4.
By Needle Type
16.7.5. By End User
17.
Competitive Benchmarking
17.1.
Market Share Analysis, 2021
17.2.
Global Presence and Growth Strategies
17.2.1.
Mergers and Acquisitions
17.2.2. Product Launches
17.2.3.
Investments Trends
17.2.4. R&D Initiatives
18.
Player Profiles
18.1.
AdvaCare Pharma
18.1.1. Company Details
18.1.2.
Company Overview
18.1.3.
Product Offerings
18.1.4.
Key Developments
18.1.5.
Financial Analysis
18.1.6. SWOT Analysis
18.1.7.
Business Strategies
18.2.
Angiplast PVT.LTD
18.2.1. Company Details
18.2.2.
Company Overview
18.2.3.
Product Offerings
18.2.4. Key Developments
18.2.5.
Financial Analysis
18.2.6.
SWOT Analysis
18.2.7.
Business Strategies
18.3.
Henry Schein Medical
18.3.1. Company Details
18.3.2.
Company Overview
18.3.3.
Product Offerings
18.3.4.
Key Developments
18.3.5. Financial Analysis
18.3.6.
SWOT Analysis
18.3.7.
Business Strategies
18.4.
iLife Medical Devices Private Limited
18.4.1. Company Details
18.4.2.
Company Overview
18.4.3.
Product Offerings
18.4.4.
Key Developments
18.4.5. Financial Analysis
18.4.6.
SWOT Analysis
18.4.7.
Business Strategies
18.5.
Lars medicare Pvt Ltd
18.5.1. Company Details
18.5.2.
Company Overview
18.5.3.
Product Offerings
18.5.4.
Key Developments
18.5.5. Financial Analysis
18.5.6.
SWOT Analysis
18.5.7.
Business Strategies
18.6.
Mediplus (India) Ltd.
18.6.1. Company Details
18.6.2.
Company Overview
18.6.3.
Product Offerings
18.6.4.
Key Developments
18.6.5. Financial Analysis
18.6.6.
SWOT Analysis
18.6.7.
Business Strategies
18.7.
Neotec Medical
18.7.1. Company Details
18.7.2.
Company Overview
18.7.3.
Product Offerings
18.7.4.
Key Developments
18.7.5. Financial Analysis
18.7.6.
SWOT Analysis
18.7.7.
Business Strategies
18.8.
Sterimed Group
18.8.1. Company Details
18.8.2.
Company Overview
18.8.3.
Product Offerings
18.8.4.
Key Developments
18.8.5. Financial Analysis
18.8.6.
SWOT Analysis
18.8.7.
Business Strategies
18.9.
Well Med India          Â
18.9.1. Company Details
18.9.2.
Company Overview
18.9.3.
Product Offerings
18.9.4.
Key Developments
18.9.5. Financial Analysis
18.9.6.
SWOT Analysis
18.9.7.
Business Strategies
18.10.
Other Market Participants
19.
Key Findings
Note: This ToC is tentative and can be changed according to the
research study conducted during the course of report completion.
**Exclusive
for Multi-User and Enterprise User.
At Absolute Markets Insights, we are engaged in building both global as well as country specific reports. As a result, the approach taken for deriving the estimation and forecast for a specific country is a bit unique and different in comparison to the global research studies. In this case, we not only study the concerned market factors & trends prevailing in a particular country (from secondary research) but we also tend to calculate the actual market size & forecast from the revenue generated from the market participants involved in manufacturing or distributing the any concerned product. These companies can also be service providers. For analyzing any country specifically, we do consider the growth factors prevailing under the states/cities/county for the same. For instance, if we are analyzing an industry specific to United States, we primarily need to study about the states present under the same(where the product/service has the highest growth). Similar analysis will be followed by other countries. Our scope of the report changes with different markets.
Our research study is mainly implement through a mix of both secondary and primary research. Various sources such as industry magazines, trade journals, and government websites and trade associations are reviewed for gathering precise data. Primary interviews are conducted to validate the market size derived from secondary research. Industry experts, major manufacturers and distributors are contacted for further validation purpose on the current market penetration and growth trends.
Prominent participants in our primary research process include:
- Key Opinion Leaders namely the CEOs, CSOs, VPs, purchasing managers, amongst others
- Research and development participants, distributors/suppliers and subject matter experts
Secondary Research includes data extracted from paid data sources:
- Reuters
- Factiva
- Bloomberg
- One Source
- Hoovers
Research Methodology
Key Inclusions
Reach to us
Call us on
+91-74002-42424
Drop us an email at
sales@absolutemarketsinsights.com
Why Absolute Markets Insights?
An effective strategy is the entity that influences a business to stand out of the crowd. An organization with a phenomenal strategy for success dependably has the edge over the rivals in the market. It offers the organizations a head start in planning their strategy. Absolute Market Insights is the new initiation in the industry that will furnish you with the lead your business needs. Absolute Market Insights is the best destination for your business intelligence and analytical solutions; essentially because our qualitative and quantitative sources of information are competent to give one-stop solutions. We inventively combine qualitative and quantitative research in accurate proportions to have the best report, which not only gives the most recent insights but also assists you to grow.